Status:

UNKNOWN

Exploring the Effectiveness of Group Cognitive Stimulation Therapy in People With Schizophrenia.

Lead Sponsor:

National Yang Ming Chiao Tung University

Conditions:

Cognitive Therapy

Eligibility:

All Genders

20-65 years

Phase:

NA

Brief Summary

Background: Cognitive dysfunction is the core defect of schizophrenia, which seriously affects the emotional, social functions and quality of life in people with schizophrenia. Objective: The purpose...

Detailed Description

Background: Cognitive dysfunction is the core defect of schizophrenia, which seriously affects the emotional and social functions of patients. Group cognitive stimulation therapy has been supported by...

Eligibility Criteria

Inclusion

  • People who according the DSM-5 diagnosis of schizophrenia spectrum and have been sick for more than two years.
  • Age between 20 and 65 years old.
  • There are currently rules for receiving antipsychotics treatment.
  • Regardless of whether you take antidepressants or not.
  • Can communicate clearly in Mandarin and Taiwanese.
  • Those with a score of 10-25 on the Montreal Cognitive Assessment Scale (MoCA).
  • Those who are willing to participate in this study and complete the subject consent form.

Exclusion

  • According to DSM-5 criteria, suspected bipolar disorder, anxiety disorder, obsessive- compulsive disorder, cognitive impairment, substance use disorders, and other unthinking disorders are exclusion.
  • Have been in or out of the acute ward within three months and currently have suicidal attempts or violence.
  • Those who are receiving individual or group cognitive behavior therapy.
  • People with intellectual disabilities.
  • Those who are unable to conduct research due to visual or hearing impairment.
  • People who are accepting other clinical trials.
  • Those who have no intention to participate in this study or are unable to complete the subject's consent form.

Key Trial Info

Start Date :

January 15 2021

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

December 31 2021

Estimated Enrollment :

90 Patients enrolled

Trial Details

Trial ID

NCT04916483

Start Date

January 15 2021

End Date

December 31 2021

Last Update

June 7 2021

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

National Yang-Ming Jiaotong University

Taipei, Taiwan